Related topics: cancer drugs ยท drug

Sorry, no news articles match your request. Your search criteria may be too narrow.


Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).

This text uses material from Wikipedia, licensed under CC BY-SA